{
    "nctId": "NCT02874222",
    "briefTitle": "A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms",
    "officialTitle": "E1Z11 A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor, AIMSS",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 13,
    "primaryOutcomeMeasure": "development of arthritic symptoms",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* \u2265 60 years of age; or\n* \\< 60 years of age and amenorrheic for \u2265 12 months prior to day 1 if uterus/ovaries are intact; or\n* \\< 60 years of age, and the last menstrual period 6-12 months prior to day 1, if intact uterus/ovaries and meets biochemical criteria for menopause (FSH and estradiol within institutional standard for postmenopausal status); or\n* \\< 60 years of age, without a uterus, and meets biochemical criteria for menopause (FSH and estradiol within institutional standards for postmenopausal status); or\n* \\< 60 years of age and history of bilateral oophorectomy. Surgery must have been completed at least 4 weeks prior to day 1; or\n* Prior radiation castration with amenorrhea for at least 6 months.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}